These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 2442116)

  • 21. Effect of alloantibodies on corneal allograft survival.
    Hegde S; Mellon JK; Hargrave SL; Niederkorn JY
    Invest Ophthalmol Vis Sci; 2002 Apr; 43(4):1012-8. PubMed ID: 11923241
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Modulation of F1 cytotoxic potentials by GvHR: role and mode of action of non-MHC genes that determine the hybrid resistance to GvHR-associated suppression of F1 cytotoxic potential.
    Ishikawa H; Kubota E; Saito K
    J Immunol; 1984 May; 132(5):2218-25. PubMed ID: 6232314
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Allogeneic cell therapy for a murine mammary carcinoma.
    Morecki S; Yacovlev E; Diab A; Slavin S
    Cancer Res; 1998 Sep; 58(17):3891-5. PubMed ID: 9731499
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A pathogenic role of IL- 17 at the early stage of corneal allograft rejection.
    Chen H; Wang W; Xie H; Xu X; Wu J; Jiang Z; Zhang M; Zhou L; Zheng S
    Transpl Immunol; 2009 Jul; 21(3):155-61. PubMed ID: 19358887
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Non-H-2-linked genetic regulation of cytotoxic responses to hapten-modified syngeneic cells. I. Non-H-2-linked Ir gene defect expressed on T cells is not predetermined at the stage of bone marrow cells.
    Ogata M; Shimizu J; Tsuchida T; Takai Y; Fujiwara H; Hamaoka T
    J Immunol; 1986 Feb; 136(4):1178-85. PubMed ID: 2935573
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Spontaneous and IL-2-induced anti-leukemic and anti-host effects against tumor- and host-specific alloantigens.
    Cohen P; Vourka-Karussis U; Weiss L; Slavin S
    J Immunol; 1993 Nov; 151(9):4803-10. PubMed ID: 8409438
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Angiogenic lymphokines of activated T-cell origin.
    Lutty GA; Liu SH; Prendergast RA
    Invest Ophthalmol Vis Sci; 1983 Dec; 24(12):1595-601. PubMed ID: 6197391
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Co-stimulated/Tc2 cells abrogate murine marrow graft rejection.
    Erdmann AA; Jung U; Foley JE; Toda Y; Fowler DH
    Biol Blood Marrow Transplant; 2004 Sep; 10(9):604-13. PubMed ID: 15319772
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Prolongation of corneal allograft survival in mice with a cyclosporine drug delivery system implant].
    Shi W; Xie L; Wang S
    Zhonghua Yan Ke Za Zhi; 2002 Aug; 38(8):502-5. PubMed ID: 12410993
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Differences in non-MHC alloantigens promote tissue rejection but fail to mediate allogeneic co-operation and autoimmunity in mice neonatally injected with semi-allogeneic F1 B cells.
    Ramos A; Merino R; Merino J
    Immunology; 1994 Jun; 82(2):287-93. PubMed ID: 7927500
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Preservation of donor cornea prevents corneal allograft rejection by inhibiting induction of alloimmunity.
    Kamiya K; Hori J; Kagaya F; Usui T; Amano S; Oshika T; Mizouchi T; Tsuru T; Yamagami S
    Exp Eye Res; 2000 Jun; 70(6):737-43. PubMed ID: 10843778
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Capability of lymphocytes, stimulated in vitro with phytohemagglutinins to accomplish the graft versus host reaction].
    Nesterenko VG; Koval'chuk LV
    Biull Eksp Biol Med; 1976 May; 81(5):579-81. PubMed ID: 7329
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Keratinocytes synthesize Ia antigen in acute cutaneous graft-vs-host disease.
    Breathnach SM; Katz SI
    J Immunol; 1983 Dec; 131(6):2741-5. PubMed ID: 6417231
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Natural suppressor (NS) activity from murine neonatal spleen is responsive to IFN-gamma.
    Maier T; Holda JH
    J Immunol; 1987 Jun; 138(12):4075-84. PubMed ID: 2953798
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Are corneal cells susceptible to antibody-mediated killing in corneal allograft rejection?
    Hargrave SL; Mayhew E; Hegde S; Niederkorn J
    Transpl Immunol; 2003; 11(1):79-89. PubMed ID: 12727479
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The role of cytotoxic T lymphocytes in corneal allograft rejection.
    Hegde S; Niederkorn JY
    Invest Ophthalmol Vis Sci; 2000 Oct; 41(11):3341-7. PubMed ID: 11006223
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Differential chemokine gene expression in corneal transplant rejection.
    Yamagami S; Miyazaki D; Ono SJ; Dana MR
    Invest Ophthalmol Vis Sci; 1999 Nov; 40(12):2892-7. PubMed ID: 10549649
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Induction of bone marrow allograft rejection and hybrid resistance in nonresponder recipients by antibody: is there evidence for a dual receptor interaction in acute marrow graft rejection?
    Dennert G; Anderson CG; Warner J
    J Immunol; 1986 Jun; 136(11):3981-6. PubMed ID: 3517162
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Corneal neovascularization. Pathogenesis and inhibition.
    Epstein RJ; Stulting RD; Hendricks RL; Harris DM
    Cornea; 1987; 6(4):250-7. PubMed ID: 2446823
    [TBL] [Abstract][Full Text] [Related]  

  • 40. ACAID induced by allogeneic corneal tissue promotes subsequent survival of orthotopic corneal grafts.
    Sonoda A; Sonoda Y; Muramatu R; Streilein JW; Usui M
    Invest Ophthalmol Vis Sci; 2000 Mar; 41(3):790-8. PubMed ID: 10711695
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.